Induced pluripotent stem cells (iPSCs) are widely regarded as a breakthrough in regenerative medicine and disease modeling. Their ability to proliferate indefinitely and differentiate into nearly any cell type makes them invaluable for drug screening, tissue repair, and personalized therapies. Yet, despite their promise, researchers continue to face significant challenges—particularly in...
In recent years, gene therapy has emerged as one of the most promising frontiers in modern medicine. By addressing diseases at their genetic roots, researchers are opening doors to treatments that were once unimaginable. Two areas of innovation—circular RNA (circRNA) detection and AAV vector design for cystic fibrosis—highlight how advanced technologies are reshaping biomedical...
Walk into any immunology lab today and you'll likely find researchers puzzling over the complement system. It's ancient, powerful, and sometimes unpredictable. For decades, scientists have known that complement proteins can protect us from infection—but they can also drive inflammation and autoimmune disease. The real challenge now is not just understanding what complement does,...
Induced pluripotent stem cells (iPSCs) are widely regarded as a breakthrough in regenerative medicine and disease modeling. Their ability to proliferate indefinitely and differentiate into nearly any cell type makes them invaluable for drug screening, tissue repair, and personalized therapies. Yet, despite their promise, researchers continue to face significant challenges—particularly in...
Glycosylation, one of the most intricate post-translational modifications, has emerged as a cornerstone in the research phase of therapeutic protein development. Particularly for monoclonal antibodies and glycoproteins, the structural diversity of glycans can dramatically influence protein behavior, affecting everything from pharmacodynamics to immunogenicity. As researchers look to optimize...
"Glycosylation is not decoration—it's communication," notes a recent review in Nature Reviews Drug Discovery (Vol. 21, 2022).
That simple statement captures why glycoproteins have become one of the most compelling frontiers in biomedical research. These sugar‑coated proteins are not passive ornaments; they are active messengers, shaping how cells talk, how the immune...
In recent years, biologics have emerged as one of the most promising frontiers in medicine. From monoclonal antibodies to engineered proteins, these therapies are reshaping how scientists approach cancer, autoimmune disorders, and infectious diseases. Yet, before any candidate reaches clinical trials, researchers must navigate a series of hurdles in the preclinical stage—manufacturing...
Biotechnology is witnessing a surge of innovation in phage discovery, with new functional screening platforms reshaping drug development and antibody engineering. Recent advancements highlight how phage display is evolving from a binding-focused tool into a powerful engine for therapeutic breakthroughs.
Functional Target Screening: Moving Beyond Binding
Traditional phage display often...
Microfluidics—a field that deals with the manipulation of fluids at the microscale—is quietly revolutionizing how we study biology, develop drugs, and diagnose disease. By channeling tiny volumes of liquid through intricately designed chips, researchers can simulate complex biological environments, perform high-throughput experiments, and reduce reagent consumption dramatically....
Traditional drug screening and disease modeling—long reliant on 2D cell cultures and animal models—are increasingly criticized for their limited predictive power and inefficiency. As the demand for personalized medicine and high-throughput testing grows, researchers face a critical question: How can we build more realistic, scalable, and responsive in vitro systems?
...
Gene therapy has entered a new era—one defined not just by bold concepts, but by molecular finesse. At the heart of this transformation are oligonucleotides: short strands of nucleic acids that can silence, edit, or regulate genes with remarkable specificity. But their journey from concept to clinic is anything but straightforward.
The Challenge: Biological Barriers
Unmodified...
Chimeric Antigen Receptor T-cell (CAR-T) therapy has revolutionized the treatment landscape for hematologic malignancies, offering targeted, durable responses where conventional therapies often fall short. But what if this cellular precision could be redirected beyond cancer—to chronic, non-oncological diseases like hemophilia or transplant rejection?
Recent advances suggest that...
Neurodegenerative diseases, characterized by the progressive loss of structure or function of neurons, including death of neurons, have become a significant global health concern. Conditions such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS) not only diminish the quality of life for millions but also pose substantial economic burdens on...
Australian researchers claimed that they have found a cure for cervical cancer in mice using gene-editing technology, which is a big breakthrough for gene therapy, and Creative Biolabs spares no effort in assisting global scientists to make greater progress.
Earlier this month, scientists from Griffiths University’s Menzies Health Institute Queensland used gene editing technology...
In the world of drug formulation research and nanotechnology, lipid-based delivery systems have captured the attention of scientists aiming to refine how materials move within biological environments. Whether you're exploring membrane mimicry or enhancing molecular stability, lipid-based systems are a flexible and intriguing platform for early-stage experimentation.
One key focus in...
The intricacies of the human immune system have been profoundly explored in recent years, revealing a wealth of knowledge that has unlocked new opportunities and methodologies for fighting diseases. One promising discovery is the concept of immune checkpoint therapy. The technology and mechanisms necessary for immune checkpoint antibody development have been under intense focus, which offers...
In the intricate realm of medical diagnostics and therapeutic advancements, antibodies targeting glycans have emerged as pivotal players. Glycans, complex sugar molecules decorating proteins and lipids, play crucial roles in cellular communication, immune responses, and disease pathogenesis. Harnessing antibodies specific to these glycans opens new avenues for diagnosis, treatment, and...
In the rapidly evolving field of cancer immunotherapy, immune checkpoint antibodies have emerged as powerful tools to modulate the immune system's response to tumors. These specialized antibodies target immune checkpoint pathways—regulatory mechanisms that normally maintain immune homeostasis but are often hijacked by cancer cells to evade immune detection. From their...
In the intricate realm of medical diagnostics and therapeutic advancements, antibodies targeting glycans have emerged as pivotal players. Glycans, complex sugar molecules decorating proteins and lipids, play crucial roles in cellular communication, immune responses, and disease pathogenesis. Harnessing antibodies specific to these glycans opens new avenues for diagnosis, treatment, and...
In the dynamic landscape of regenerative medicine, induced pluripotent stem cells (iPSCs) have revolutionized the way researchers approach cell-based therapies and disease modeling. Among the most promising applications is the generation of neural crest cells, Schwann cells, and astrocytes—three critical cell types that play essential roles in the development and maintenance of the...
Chinese
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Romaian
Portuguese (Brazil)
Greek